Suzan M. Mansour

473 total citations
23 papers, 366 citations indexed

About

Suzan M. Mansour is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine and Physiology. According to data from OpenAlex, Suzan M. Mansour has authored 23 papers receiving a total of 366 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Molecular Biology, 5 papers in Pulmonary and Respiratory Medicine and 4 papers in Physiology. Recurrent topics in Suzan M. Mansour's work include Inhalation and Respiratory Drug Delivery (3 papers), Tryptophan and brain disorders (3 papers) and Pharmacological Effects of Natural Compounds (2 papers). Suzan M. Mansour is often cited by papers focused on Inhalation and Respiratory Drug Delivery (3 papers), Tryptophan and brain disorders (3 papers) and Pharmacological Effects of Natural Compounds (2 papers). Suzan M. Mansour collaborates with scholars based in Egypt, United States and Poland. Suzan M. Mansour's co-authors include A. Bahgat, Mohamed T. Khayyal, Aiman S. El‐Khatib, Azza A. Mahmoud, Hend I. Shahin, Mahavir B. Chougule, Marwa M. Safar, Hala M. Fawzy, Amany M. Gad and Lipika Chablani and has published in prestigious journals such as Journal of Controlled Release, International Journal of Pharmaceutics and Life Sciences.

In The Last Decade

Suzan M. Mansour

18 papers receiving 358 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Suzan M. Mansour Egypt	12	81	76	59	48	43	23	366
Hemat El‐Sayed El‐Horany Egypt	11	132 1.6×	55 0.7×	51 0.9×	23 0.5×	53 1.2×	36	412
Mohamed K. El-Kherbetawy Egypt	16	196 2.4×	24 0.3×	13 0.2×	47 1.0×	62 1.4×	36	609
Md Sayeed Akhtar Saudi Arabia	13	156 1.9×	27 0.4×	27 0.5×	39 0.8×	28 0.7×	40	532
Soad Z. El‐Emam Egypt	11	126 1.6×	16 0.2×	35 0.6×	36 0.8×	47 1.1×	21	351
Masafumi Funamoto Japan	16	313 3.9×	28 0.4×	23 0.4×	32 0.7×	121 2.8×	61	732
Abdulmajeed M. Jali Saudi Arabia	14	147 1.8×	19 0.3×	42 0.7×	22 0.5×	39 0.9×	33	395
Cen Guo United States	13	155 1.9×	25 0.3×	17 0.3×	27 0.6×	22 0.5×	25	634
Amir Ghorbani Haghjo Iran	12	157 1.9×	33 0.4×	9 0.2×	27 0.6×	51 1.2×	17	532
Wael M. Elsaed Egypt	14	141 1.7×	27 0.4×	10 0.2×	17 0.4×	26 0.6×	40	421
Sattam Khulaif Alenezi Saudi Arabia	11	130 1.6×	22 0.3×	65 1.1×	32 0.7×	18 0.4×	29	360

Countries citing papers authored by Suzan M. Mansour

Since Specialization

Citations

This map shows the geographic impact of Suzan M. Mansour's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Suzan M. Mansour with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Suzan M. Mansour more than expected).

Fields of papers citing papers by Suzan M. Mansour

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Suzan M. Mansour. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Suzan M. Mansour. The network helps show where Suzan M. Mansour may publish in the future.

Co-authorship network of co-authors of Suzan M. Mansour

This figure shows the co-authorship network connecting the top 25 collaborators of Suzan M. Mansour. A scholar is included among the top collaborators of Suzan M. Mansour based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Suzan M. Mansour. Suzan M. Mansour is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

El‐Abhar, Hanan S., et al.. (2025). Neuroprotective role of mirabegron: Targeting beta-3 adrenergic receptors to alleviate ulcerative colitis-associated cognitive impairment. Biomedicine & Pharmacotherapy. 183. 117816–117816.

El‐Abhar, Hanan S., et al.. (2025). Dual inhibition of canonical and noncanonical PAR‐1 by SCH79797 mitigates neurodegeneration in 3‐NP‐induced Huntington's disease: An in vivo and in silico approach. Archiv der Pharmazie. 358(3). e2400846–e2400846.

El‐Abhar, Hanan S., et al.. (2025). Resatorvid as a promising neuroprotective agent in pentylenetetrazol-kindling rat model: Suppressing neuroinflammation and enhancing cognitive and motor functions. European Journal of Pharmacology. 1006. 178160–178160.

Salem, Mohamed A., et al.. (2025). Unlocking dexmedetomidine's therapeutic potential in multiple sclerosis: Dual modulation of PI3K/Akt/BDNF and TLR4/NF-κB pathways in EAE rats. European Journal of Pharmacology. 1008. 178365–178365.

Mansour, Suzan M., et al.. (2024). Novel insights into gut health: Cilostazol strengthens gut integrity by adjusting TLR-2/NF-κB/IL-23 and CD44/AKT/GSK-3β/cyclin-D1 trajectories in methotrexate-induced mucositis model. European Journal of Pharmacology. 975. 176669–176669. 3 indexed citations

Ammar, Hussein O., et al.. (2022). Artificial intelligence-assisted development ofin situforming nanoparticles for arthritis therapy via intra-articular delivery. Drug Delivery. 29(1). 1423–1436. 16 indexed citations

Mansour, Suzan M., et al.. (2021). Vitamin D Combined with Pioglitazone Mitigates Type-2 Diabetes-induced Hepatic Injury Through Targeting Inflammation, Apoptosis, and Oxidative Stress. Inflammation. 45(1). 156–171. 16 indexed citations

Mansour, Suzan M., Rehab Nabil Shamma, Kawkab A. Ahmed, et al.. (2021). Safety of inhaled ivermectin as a repurposed direct drug for treatment of COVID-19: A preclinical tolerance study. International Immunopharmacology. 99. 108004–108004. 16 indexed citations

Salem, Mohamed A., et al.. (2021). Tadalafil and bergapten mitigate streptozotocin-induced sporadic Alzheimer's disease in mice via modulating neuroinflammation, PI3K/Akt, Wnt/β-catenin, AMPK/mTOR signaling pathways. Toxicology and Applied Pharmacology. 429. 115697–115697. 44 indexed citations

10.

Shahin, Hend I., et al.. (2021). Formulation and optimization of sildenafil citrate-loaded PLGA large porous microparticles using spray freeze-drying technique: A factorial design and in-vivo pharmacokinetic study. International Journal of Pharmaceutics. 597. 120320–120320. 25 indexed citations

11.

Mansour, Suzan M., et al.. (2021). Sodium hydrogen sulfide upregulates cystathionine β-synthase and protects striatum against 3-nitropropionic acid-induced neurotoxicity in rats. Journal of Pharmacy and Pharmacology. 73(3). 310–321. 15 indexed citations

12.

Mansour, Suzan M., Hanan S. El‐Abhar, & Ayman A. Soubh. (2020). MiR-200a inversely correlates with Hedgehog and TGF-β canonical/non-canonical trajectories to orchestrate the anti-fibrotic effect of Tadalafil in a bleomycin-induced pulmonary fibrosis model. Inflammopharmacology. 29(1). 167–182. 17 indexed citations

13.

Ghoneim, Amira M. & Suzan M. Mansour. (2020). <p>The Effect of Liver and Kidney Disease on the Pharmacokinetics of Clozapine and Sildenafil: A Physiologically Based Pharmacokinetic Modeling</p>. Drug Design Development and Therapy. Volume 14. 1469–1479. 10 indexed citations

14.

Gad, Amany M., et al.. (2019). Venlafaxine alleviates complete Freund's adjuvant-induced arthritis in rats: Modulation of STAT-3/IL-17/RANKL axis. Life Sciences. 226. 68–76. 19 indexed citations

15.

Shahin, Hend I., Azza A. Mahmoud, Rehab Nabil Shamma, et al.. (2019). Design and evaluation of novel inhalable sildenafil citrate spray-dried microparticles for pulmonary arterial hypertension. Journal of Controlled Release. 302. 126–139. 54 indexed citations

16.

Gad, Amany M., et al.. (2018). Novel Anti-arthritic Mechanisms of Polydatin in Complete Freund’s Adjuvant-Induced Arthritis in Rats: Involvement of IL-6, STAT-3, IL-17, and NF-кB. Inflammation. 41(5). 1974–1986. 30 indexed citations

17.

Zaki, Hala F., et al.. (2013). Chromium Picolinate and Rosiglitazone Improve Biochemical Derangement in a Rat Model of Insulin Resistance: Role of TNF-a and Leptin. Pharmacologia. 4(3). 186–196. 2 indexed citations

18.

Mansour, Suzan M., et al.. (2012). Beneficial effects of co-enzyme Q10 and rosiglitazone in fructose-induced metabolic syndrome in rats. Bulletin of Faculty of Pharmacy Cairo University . 51(1). 13–21. 8 indexed citations

19.

Mansour, Suzan M., A. Bahgat, Aiman S. El‐Khatib, & Mohamed T. Khayyal. (2011). Ginkgo biloba extract (EGb 761) normalizes hypertension in 2K, 1C hypertensive rats: Role of antioxidant mechanisms, ACE inhibiting activity and improvement of endothelial dysfunction. Phytomedicine. 18(8-9). 641–647. 64 indexed citations

20.

El-Karaksy, Hanaa, et al.. (2009). Cost-effectiveness of prescreening versus empirical vaccination for hepatitis A in Egyptian children with chronic liver disease.. PubMed. 14(4). 804–9. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact